Analysis of prevalence of HIV-1 drug resistance in primary infections in the United Kingdom
- PMID: 11337435
- PMCID: PMC31258
- DOI: 10.1136/bmj.322.7294.1087
Analysis of prevalence of HIV-1 drug resistance in primary infections in the United Kingdom
Abstract
Objectives: To identify changes since 1994 in the prevalence of resistance to anti-HIV drugs in primary HIV-1 infections in the United Kingdom.
Design: Retrospective and prospective assessment of viruses obtained from people recently infected with HIV.
Setting: Multiple centres (patients enrolled in the UK register of seroconverters) and a single large HIV clinic (active case ascertainment).
Participants: 69 patients infected with HIV between June 1994 and August 2000.
Main outcome measures: Prevalence of key mutations associated with drug resistance in the reverse transcriptase and protease genes of HIV-1, by year of infection.
Results: Between June 1994 and August 2000, 10 (14%) of 69 newly infected patients had one or more key HIV-1 mutations associated with drug resistance. The risk of being infected with drug resistant virus increased over time (adjusted relative risk per year 1.74 (95% confidence interval 0.93 to 3.27), P=0.06). The estimated prevalence of drug resistance in those infected in 2000 was 27% (12% to 48%).
Conclusions: Transmission of drug resistant HIV-1 in the United Kingdom seems to be increasing. New approaches to encourage safer sexual behaviour in all sectors of the population are urgently needed.
Comment in
-
Is transmitted drug resistance in HIV on the rise? It seems so.BMJ. 2001 May 5;322(7294):1074-5. doi: 10.1136/bmj.322.7294.1074. BMJ. 2001. PMID: 11337420 Free PMC article. No abstract available.
References
-
- AIDS and HIV infection in the United Kingdom: monthly report. Communicable Disease Report Weekly. 2000;10:37–40. - PubMed
-
- Yerly S, Kaiser L, Race E, Bru JP, Clavel F, Perrin L. Transmission of antiretroviral-drug-resistant HIV-1 variants. Lancet. 1999;354:729–733. - PubMed
-
- UK Register of HIV Seroconverters Steering Committee. The AIDS incubation period in the UK estimated from a national register of HIV seroconverters. AIDS. 1998;12:659–667. - PubMed
-
- Pillay D, Cane PA, Shirley J, Porter K. Detection of drug resistance associated mutations in HIV primary infection within the UK. AIDS. 2000;14:906–908. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical